[1]
A. PRANCULIS, Z. A. KUČINSKIENĖ, and V. KUČINSKAS, “Pharmacogenomics: a perspective of personalized medicine in CHD treatment as a model”, AML, vol. 18, no. 2, pp. 70–78, Apr. 2011, doi: 10.6001/actamedica.v18i2.1818.